In sum, these studies suggest that TAM-associated tumor cell proliferation occurs in an IL-6 or IL-10/STAT3 signal cascade dependent manner and targeting proteins in the IL-6 or IL-10/STAT3 signaling pathway to attenuate tumor cell proliferation is promising in anti-tumor therapies. The gene discussed is IL6; the disease is neoplasm.